Full history for every metric is available with a Kvantra account
Covetrus, Inc. (CVET)
Key financial summary
Financials in USD| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 3,353 | 3,580 | 3,778 | 3,976 | 4,339 | 4,575 | 4,649 |
| Operating profit | $m | -22 | 4 | |||||
| Net profit | $m | 70 | 64 | 101 | -1,019 | -19 | -86 | -13 |
| EPS reported | $ | -0.63 | -0.09 | |||||
| Operating cashflow per share | $ | 0.74 | 0.74 | |||||
| Capex per share | $ | 0.44 | 0.44 | |||||
| FCF per share | $ | 0.31 | 0.31 | |||||
| Free cash flow | $m | 42 | 2 | |||||
| Net debt | $m | 863 | 962 | |||||
| Book value equity | $m | 1,511 | 1,505 | |||||
| Book value per share | $ | 11.03 | 10.75 | |||||
| Number of shares | m | 137 | 140 | |||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 1.81 | 1.95 | |||||
| P/S LTM | x | 0.60 | 0.63 | |||||
| P/FCF LTM | x | 65.14 | 1,469.30 | |||||
| EV/EBITDA LTM | x | 20.11 | 19.21 | |||||
| EV/Sales LTM | x | 0.79 | 0.84 | |||||
| Earnings Yield LTM | % | -3.14% | -2.99% | |||||
| FCF Yield | % | 1.54% | 0.07% | |||||
| Quality | ||||||||
| ROE | % | -5.69% | -5.64% | |||||
| ROIC | % | -0.80% | -0.80% | |||||
| Operating margin | % | -0.48% | -0.48% | |||||
| Gross margin | % | 18.75% | 18.75% | |||||
| FCF/Sales | % | 0.92% | 0.92% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | +5.44% | +2.42% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | 0.04 | 0.00 | |||||
| Net Debt/EBITDA | x | 4.82 | 4.82 | |||||
| EBIT/Net interest | x | -0.69 | -0.69 | |||||
| Net debt/market cap | % | 31.54% | 32.74% | |||||
| Net debt/Equity | x | 0.57 | 0.64 | |||||
| Gross debt/equity | x | 0.69 | 0.70 | |||||
Company overview
Covetrus, Inc. functions as a technology and services provider for the animal health sector. The company supplies a comprehensive range of animal health consumables, including its own branded and proprietary items, along with diverse equipment (small and large), laboratory supplies, and associated repair services. It further offers a full spectrum of pharmaceuticals—encompassing branded, generic, and vaccine products, surgical instruments, diagnostic kits, infection control solutions, parasiticides, and nutritional supplements—to both wholesale and retail clients. Beyond physical goods, Covetrus delivers critical value-added services such as inventory management, e-commerce platforms, and professional development programs for veterinary practitioners. Its technology portfolio includes practice management software, data analytics applications, and client communication tools aimed at boosting operational efficiency and enhancing business health. These integrated offerings extend to client reminders, data backup, hardware sales and support, and credit card processing capabilities for veterinary practices and clinics. Additionally, the company manages the distribution of finished pharmaceutical products and offers specialty compounding services, complemented by logistics, manufacturer incentives, and data integration support. Covetrus supports veterinary practices and animal health clinics across the companion animal, equine, and livestock sectors, primarily within North America, Europe, and the Asia Pacific. Established in 2018 under the name HS Spinco, Inc. and headquartered in Portland, Maine, Covetrus, Inc. transitioned to private ownership on October 13, 2022.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Covetrus, Inc. (CVET)
Covetrus, Inc. functions as a technology and services provider for the animal health sector. The company supplies a comprehensive range of animal health consumables, including its own branded and proprietary items, along with diverse equipment (small and large), laboratory supplies, and associated repair services. It further offers a full spectrum of pharmaceuticals—encompassing branded, generic, and vaccine products, surgical instruments, diagnostic kits, infection control solutions, parasiticides, and nutritional supplements—to both wholesale and retail clients. Beyond physical goods, Covetrus delivers critical value-added services such as inventory management, e-commerce platforms, and professional development programs for veterinary practitioners. Its technology portfolio includes practice management software, data analytics applications, and client communication tools aimed at boosting operational efficiency and enhancing business health. These integrated offerings extend to client reminders, data backup, hardware sales and support, and credit card processing capabilities for veterinary practices and clinics. Additionally, the company manages the distribution of finished pharmaceutical products and offers specialty compounding services, complemented by logistics, manufacturer incentives, and data integration support. Covetrus supports veterinary practices and animal health clinics across the companion animal, equine, and livestock sectors, primarily within North America, Europe, and the Asia Pacific. Established in 2018 under the name HS Spinco, Inc. and headquartered in Portland, Maine, Covetrus, Inc. transitioned to private ownership on October 13, 2022.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free